The extensive linkages between India and UK have a huge scope in creating a positive impact on the talent and recruitment industry, writes Yogita Tulsiani
Serum Institute to invest 240 million pounds in UK, expand vaccine business
Serum Institute to invest 240 million pounds in UK, expand vaccine business
The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business and set up a new sales office creating a large number of jobs, Downing Street has announced as part of plans for a GBP 1 billion India-UK Enhanced Trade Partnership.
advertisement
UPDATED: May 4, 2021 09:19 IST
The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business. (Reuters)
The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business and set up a new sales office creating a large number of jobs, Downing Street has announced as part of plans for a GBP 1 billion India-UK Enhanced Trade Partnership creating around 6,500 jobs in Britain. The Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors such as healthcare, bio
Serum Institute to invest 240 million pounds in UK; leads cross-sector Indian investments
SECTIONS
Last Updated: May 04, 2021, 09:28 AM IST
Share
Synopsis
The Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors such as healthcare, biotech and software services to announce significant investment plans in the UK.
Agencies
It was also revealed that the Serum Institute of India (SII) has started phase one trials in the UK of a nasal vaccine against coronavirus.
The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business and set up a new sales office creating a large number of jobs, Downing Street has announced as part of plans for a GBP 1 billion India-UK Enhanced Trade Partnership creating around 6,500 jobs in Britain. The Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors such as healthcare, biotech and software services to announce significant investment pla
Adar Poonawalla s Serum Institute to invest 240 mn pounds to expand vaccine business in UK
Serum Institute of India (SII), which is known globally for its vaccine production capacity is among 20 Indian companies across sectors (healthcare, biotech and software services) to announce massive investment plans in the UK
BusinessToday.In | May 4, 2021 | Updated 13:05 IST
Adar Poonawalla Adar Poonawalla-helmed Serum Institute will pump in 240 million British pounds to expand its vaccine business and setting up a new sales office in the UK. This investment is part of plans for 1 billion British pound India-UK Enhanced Trade Partnership, which will create approximately 6,500 jobs in the UK, Downing Street announced.
London: The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business and set up a new sales office creating a large